4.8 Article

The nuclear hormone receptor PPARγ counteracts vascular calcification by inhibiting Wnt5a signalling in vascular smooth muscle cells

期刊

NATURE COMMUNICATIONS
卷 3, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms2087

关键词

-

资金

  1. la Fondation pour la Recherche Medicale (FRM)
  2. centre national pour la recherche scientifique (CNRS)
  3. University of Strasbourg
  4. Fondation de France
  5. Agence Nationale de la Recherche [ANR-06-PHYSIO-032-01, ANR-09-BLAN-0121-01]
  6. National Institutes of Health
  7. American Health Assistance Foundation
  8. Perot Family Foundation
  9. Consortium for Frontotemporal Dementia Research (CFR)
  10. Wolfgang-Paul Program of the Humboldt Foundation
  11. Agence Nationale de la Recherche (ANR) [ANR-09-BLAN-0121] Funding Source: Agence Nationale de la Recherche (ANR)

向作者/读者索取更多资源

Vascular calcification is a hallmark of advanced atherosclerosis. Here we show that deletion of the nuclear receptor PPAR. in vascular smooth muscle cells of low density lipoprotein receptor (LDLr)-deficient mice fed an atherogenic diet high in cholesterol, accelerates vascular calcification with chondrogenic metaplasia within the lesions. Vascular calcification in the absence of PPAR. requires expression of the transmembrane receptor LDLr-related protein-1 in vascular smooth muscle cells. LDLr-related protein-1 promotes a previously unknown Wnt5a-dependent prochondrogenic pathway. We show that PPAR. protects against vascular calcification by inducing the expression of secreted frizzled-related protein-2, which functions as a Wnt5a antagonist. Targeting this signalling pathway may have clinical implications in the context of common complications of atherosclerosis, including coronary artery calcification and valvular sclerosis.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据